Computer-controlled chemical synthesis using flow chemistry microreactors is the key enabling technology for the chemistry laboratory of the future. Early adopters of this ground-breaking technology describe current and future uses in medicinal chemistry.
Computer-controlled chemical synthesis using flow chemistry microreactors is the key enabling technology for the chemistry laboratory of the future. Early adopters of this ground-breaking technology describe current and future uses in medicinal chemistry.
Esther Alza is the Manager of ERTFLOW at the Institute of Chemical Research of Catalonia (ICIQ), in Tarragona, Spain. Having obtained her PhD from ICIQ working on asymmetric catalysis and flow chemistry, she moved to the University of Cambridge as a Wellcome Trust Postdoctoral Fellow to work on medicinal chemistry. After this, she returned to ICIQ to lead the establishment of ERTFLOW as technology development unit and future spin-off company.
Inhaltsangabe
Chemistry at the Extremes: Turning Complex Reactions into Scalable Processes Automated Flow Chemistry Platforms Flow Chemistry Opportunities for Drug Discovery Flow Chemistry in Medicinal Chemistry - Applications to Bcr-Abl Kinase Inhibitors Integrated Systems for Continuous Synthesis and Biological Screenings Application of Continuous Flow Processing in Multistep API and Drug Syntheses Continuous Flow Multistep Synthesis of Active Pharmaceutical Ingredients Enantioselective (Bio)Catalysis in Continuous-Flow as Efficient Tool for the Synthesis of Advanced Intermediates and Active Pharmaceutical Ingredients Innovative Process Development of Pharmaceutical Intermediates Under Continuous-Flow System
Chemistry at the Extremes: Turning Complex Reactions into Scalable Processes Automated Flow Chemistry Platforms Flow Chemistry Opportunities for Drug Discovery Flow Chemistry in Medicinal Chemistry - Applications to Bcr-Abl Kinase Inhibitors Integrated Systems for Continuous Synthesis and Biological Screenings Application of Continuous Flow Processing in Multistep API and Drug Syntheses Continuous Flow Multistep Synthesis of Active Pharmaceutical Ingredients Enantioselective (Bio)Catalysis in Continuous-Flow as Efficient Tool for the Synthesis of Advanced Intermediates and Active Pharmaceutical Ingredients Innovative Process Development of Pharmaceutical Intermediates Under Continuous-Flow System
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
